Marcus Paul Kelly

Marcus Paul Kelly

Regeneron Pharmaceuticals Inc - Warsaw / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4416108
-
person_outline Marcus Paul Kelly's MOST POPULAR ARTICLES
1-) Bispecific antibodies and antibody–drug conjugates (ADCs) bridging HER2 and prolactin receptor improve efficacy of HER2 ADCsJ Andreev, N Thambi, AE Perez Bay, F Delfino, J Martin, MP Kelly, ...Molecular cancer therapeutics 16 (4), 681-693, 20171362017
2-) Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificityT Tsuji, J Matsuzaki, MP Kelly, V Ramakrishna, L Vitale, LZ He, T Keler, ...The Journal of Immunology 186 (2), 1218-1227, 20111362011
3-) Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetaseMP Kelly, AA Jungbluth, BW Wu, J Bomalaski, LJ Old, G RitterBritish journal of cancer 106 (2), 324-332, 20121262012
4-) A gene differentially expressed in the kidney of the spontaneously hypertensive rat cosegregates with increased blood pressure.NJ Samani, D Lodwick, M Vincent, C Dubay, MA Kaiser, MP Kelly, M Lo, ...The Journal of clinical investigation 92 (2), 1099-1103, 19931191993
5-) A Mucin 16 bispecific T cell–engaging antibody for the treatment of ovarian cancerA Crawford, L Haber, MP Kelly, K Vazzana, L Canova, P Ram, A Pawashe, ...Science translational medicine 11 (497), eaau7534, 20191162019